Evaluation of methods to assess the quality of cryopreserved Solanaceae pollen.

Solanaceae pollen cryopreservation is a common practice in the hybrid seed production industry worldwide, enabling effective hybridization across geographical and seasonal limitations. As pollination with low quality pollen can result in significant seed yield loss, monitoring the pollen quality has become an important risk management tool. In this study, pollen quality analysis methods were evaluated for their suitability for routine quality control of cryopreserved pollen batches. The assessments, including pollen viability, pollen germinability and pollen vigor analysis, were conducted in two locations on a diverse set of cryopreserved tomato and pepper pollen batches. While the viability obtained by Impedance Flow Cytometry (IFC) can be interpreted as the pollen's potential to germinate, the in vitro germination assay directly quantifies this functionality under given assay conditions. A linear correlation was found between pollen viability obtained by IFC and in vitro germinability. In conclusion, IFC is the most suitable tool for applications and industries requiring a high degree of automation, throughput, repeatability, and reproducibility. In vitro germination assays are suitable for studies within certain temporal and geographic limitations, due to difficulties in standardization. On the other hand, vigor assessments are not sufficiently addressing the needs of the industry due to poor reproducibility and low throughput.

Communicating to and engaging with the public in regulatory science.

This paper presents selected highlights from the 'Engaging with society' session of EFSA's third Scientific Conference 'Science, Food and Society' (Parma, Italy, 18-21 September 2018). The social dimension for scientific advisory bodies largely concerns science communication and public engagement. The political, economic and technological transformation of contemporary societies is challenging conventional structures and approaches in these areas. The disintermediation of communication and the proliferation of misinformation, it is argued, herald the onset of the post-truth society. A better understanding of the way individuals consume information today has led to the development of tools to guide mediators such as journalists and communication specialists in countering these trends. Public engagement can reinforce confidence in regulatory bodies and potentially contribute to the quality of the scientific process. Scientific advisory bodies in Europe have created strategies and mechanisms to engage the public that are designed to increase transparency and representativeness. To be effective, several engagement mechanisms are needed, although factors such as resource constraints, institutional culture and public/stakeholder attitudes may limit their development. In conclusion, a more vigorous role for social research is needed to place scientific risk assessment within broader socio-economic and political contexts. Social science expertise can help to define more impactful public information strategies and to explore the potential opportunities that engaged stakeholders and citizens can make to sustain and strengthen regulatory science.

Implementation of the nutrition and health claim regulation - the case of antioxidants.

This article analyses the consequences of the implementation of the nutrition and health claim regulation in the field of food products containing antioxidants or food products claiming antioxidant activity. To this end, it first examines the origin and creation of the regulation and the involvement of EFSA in assessing scientific substantiation of health claims. Three criteria are regarded as critical in EFSA's opinions on the scientific substantiation of a health claim: the claimed effect (i) is well defined; (ii) is a clear beneficial physiological effect; and (iii) shows a cause effect relationship with the consumption of the food or functional ingredient. These criteria have implications for the research requested to substantiate health claims, although these implications do not all seem to fit nutrition research as it is currently executed. Looking at antioxidants, the complexity of the mechanisms and actions of antioxidants is not recognised by the criteria used to evaluate proposed health claims, nor by the methodologies used to assess the effects of antioxidants. These criteria should be adjusted with novel scientific insights after consulting stakeholders.

Status of nutrition and health claims in Europe.

Functional foods are closely associated with claims on foods. There are two categories of claims on foods: nutrition claims and health claims. Health claims on (functional) foods must be scientifically substantiated. In December 2006, the European Union published its Regulation 1924/2006 on nutrition and health claims made on foods. As concerns scientific evaluation, the EU-project PASSCLAIM resulted in a set of criteria for the scientific substantiation of health claims on foods. The European Food Safety Authority provides the scientific advise to the European Commission for health claims submitted under Regulation 1924/2006 and has hitherto published several hundreds of opinions on health claims, part of which are positive, part which are negative and a few with insufficient evidence. Antioxidant claims have been approved for the general function of vitamins but not for direct health effects in humans. Another issue with claims is consumer understanding. Consumers can hardly distinguish between graded levels of evidence, and they do make only little or no distinction between nutrition and health claims. Consumers understand nutrition and health claims different from scientists and regulators. Therefore, innovation in industry can readily proceed via approved nutrition claims and approved health claims. The market and the shelves in the stores will not be empty; rather they will look different in the years to come.

Theory of mind in schizophrenia: meta-analysis.

BACKGROUND: Mentalising impairment (an impaired ability to think about people in terms of their mental states) has frequently been associated with schizophrenia. AIMS: To assess the magnitude of the deficit and analyse associated factors. METHOD: Twenty-nine studies of mentalising in schizophrenia (combined n=1518), published between January 1993 and May 2006, were included to estimate overall effect size. Study descriptors predicted to influence effect size were analysed using weighted regression-analysis techniques. Separate analyses were performed for symptom subgroups and task types. RESULTS: The estimated overall effect size was large and statistically significant (d=-1.255, P<0.0001) and was not significantly affected by sample characteristics. All symptom subgroups showed significant mentalising impairment, but participants with symptoms of disorganisation were significantly more impaired than the other subgroups (P<0.01). CONCLUSIONS: This meta-analysis showed significant and stable mentalising impairment in schizophrenia. The finding that patients in remission are also impaired favours the notion that mentalising impairment represents a possible trait marker of schizophrenia.